A Novel Mutation in the Promoter Region of the β-Globin Gene: HBB: c.-127G > C

• Published in: Hemoglobin Vol. 40; no. 4; pp. 280 - 282
• Main Authors: Bilgen, Turker, Canatan, Duran, Delibas, Serpil, Keser, Ibrahim
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 03.07.2016
• Subjects: beta-Globins - genetics; beta-Thalassemia - genetics; Humans; Keywords β-Globin; Pedigree; Phenotype; Point Mutation; promoter region; Promoter Regions, Genetic - genetics; Sequence Analysis, DNA; β-thalassemia (β-thal); promoter region; β-thalassemia (β-thal); Keywords β-Globin
• ISSN: 0363-0269; 1532-432X
• DOI: 10.1080/03630269.2016.1193513

Novel β-globin gene mutations are still occasionally being reported, especially when evaluating milder phenotypes. We report here a novel putative mutation in the promoter region of the β-globin gene and assess its clinical implications. A family, parents and four siblings, with hematological and clinical features suspected of being β-globin gene mutation(s), were involved in this study. In addition to hematological and clinical evaluations of the whole family, molecular analyses of the β-globin gene were performed by direct sequencing. Sequencing of the β-globin gene revealed a novel genomic alteration in the regulatory region of the gene. This novel genomic alteration was defined as HBB: c.-127G > C according to the Human Genome Variation Society (HGVS) nomenclature. Two siblings were found to be carriers of the HBB: c.-127G > C mutation, while the other two siblings were carriers of the codon 8 (−AA) (HBB: c.25_26delAA) deletion of the β-globin gene. The mother was a compound heterozygote for the codon 8 and HBB: c.-127G > C mutations. Based on hematological and clinical evaluations, we conclude that this novel β-globin gene promoter region change would be associated with a mild phenotype of β-thalassemia (β-thal).